financetom
DOW
financetom
/
Materials
/
DOW
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Dow Inc.DOW
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Dow Inc., through its subsidiaries, engages in the provision of various materials science solutions for packaging, infrastructure, mobility, and consumer applications in the United States, Canada, Europe, the Middle East, Africa, India, the Asia Pacific, and Latin America.

It operates through Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings segments.

The Packaging & Specialty Plastics segment provides ethylene, and propylene and aromatics products; and polyethylene, polyolefin elastomers, ethylene vinyl acetate, and ethylene propylene diene monomer rubbers for mobility and transportation, consumer, wire and cable, and construction end-markets.

The Industrial Intermediates & Infrastructure segment offers purified ethylene and propylene oxides, ethylene and ethanol amines, propylene glycol and polyether polyols, aromatic isocyanates and polyurethane systems, coatings, adhesives, sealants, elastomers, and composites.

This segment also provides caustic soda, and ethylene dichloride and vinyl chloride monomers; and cellulose ethers, redispersible latex powders, and acrylic emulsions.

The Performance Materials and Coatings segment provides architectural paints and coatings, and industrial coatings that are used in maintenance and protective industries, wood, metal packaging, traffic markings, thermal paper, and leather; and silicon metal, siloxanes, and intermediates used as key materials in manufacturing differentiated downstream silicone products.

It also engages in property and casualty insurance, as well as reinsurance business. Dow Inc. was incorporated in 2018 and is headquartered in Midland, Michigan.

Latest News >
Medical Properties Trust Prioritizes California Investments in Prospect Medical Group Chapter 11
Medical Properties Trust Prioritizes California Investments in Prospect Medical Group Chapter 11
Jan 13, 2025
05:01 AM EST, 01/13/2025 (MT Newswires) -- Medical Properties Trust ( MPW ) said Sunday that it is prioritizing the protection of its investments in Prospect Medical Group's California hospitals as Prospect commences Chapter 11 bankruptcy restructuring. While Prospect's California facilities have reported volume growth and improved coverage trends in 2024, its overall liquidity has been adversely impacted by stalled...
Biden admin delays enforcement of order blocking Nippon Steel, US Steel deal, companies say
Biden admin delays enforcement of order blocking Nippon Steel, US Steel deal, companies say
Jan 13, 2025
WASHINGTON (Reuters) -The Biden administration delayed until June an order for Nippon Steel to abandon its $14.9 billion bid for U.S. Steel, the companies said on Saturday, giving them some time to revive the politically contentious deal. President Joe Biden blocked the acquisition on national security grounds on Jan. 3, and Treasury Secretary Janet Yellen said this week the proposed...
AirBaltic IPO could be pushed back until early 2026, CEO says
AirBaltic IPO could be pushed back until early 2026, CEO says
Jan 13, 2025
DUBLIN, Jan 13 (Reuters) - AirBaltic's initial public offering (IPO) could be pushed back until early 2026, the Latvian airline's chief executive said on Monday. CEO Martin Gauss said the airline was still looking for a pre-IPO strategic investor ahead of the offering that was initially planned for last year. ...
Molecular Partners Expands Clinical Collaboration With Orano Med to Add 6 Targeted Alpha Radio-Therapies for Cancer
Molecular Partners Expands Clinical Collaboration With Orano Med to Add 6 Targeted Alpha Radio-Therapies for Cancer
Jan 13, 2025
05:26 AM EST, 01/13/2025 (MT Newswires) -- Molecular Partners AG ( MOLN ) expanded its strategic collaboration with Orano Med to include the development of an additional six targeted alpha radio-therapies for cancer, the companies said Sunday. The companies entered into an initial agreement in January 2024 to co-develop four programs. Under the expanded collaboration, Molecular Partners ( MOLN )...
Copyright 2023-2025 - www.financetom.com All Rights Reserved